Dual Diagnosis
Conditions
Keywords
Alcohol use disorder, Depression, Mood disorders, Bipolar disorder, Supportive text messages
Brief summary
Most patients who present with problem drinking also present with mood problems. Problem drinking and mood problems co-occurring together in individuals lead them to have more severe symptoms, greater disability and poorer quality of life than individuals with only problem drinking, and they pose a greater economic burden to society due to their higher use of health services. This study aims to assess the efficacy of a new, innovative and cost effective treatment strategy aimed at reducing the burden that these co-occurring conditions impose on the suffers and their families as well as the community and health systems. In a recent pilot study of supportive text messages for patients with problem drinking and co-occurring depression, the investigators established that patients who received twice daily supportive text messages for three months had significantly less depressive symptoms than those who did not receive such messages. There was also a trend to finding that patients who received the supportive text messages were more likely to have higher alcohol free days than those who did not receive any supportive text messages. This study seeks to extend the knowledge gained from the pilot study. A larger group of patients with alcohol use disorder and a depressive disorder will be randomly assigned to two groups. One group will receive supportive text messages for six months duration whilst the other group will receive no supportive text messages. The patients will be followed up at 3, 6, 9 and 12 months to determine which of the two groups have less alcohol and mood problems. It is anticipated that patients receiving supportive text messages will report significantly greater alcohol free days as well as significantly less relapses, hospitalizations and mood symptoms than those not receiving such messages.
Detailed description
Co-morbidity of alcohol use disorder (AUD) and mood disorders presents a great challenge to health systems and exacts a tremendous toll world-wide. Individuals with a dual diagnosis have more severe symptoms, greater disability and poor quality of life than those with either diagnosis alone, and pose a greater economic burden to society due to their higher use of treatment services. New, enhanced, efficient, innovative and cost effective treatment strategies aimed at reducing the burden that the disorders impose on the suffers and their families as well as the community and health systems are required. In a pilot trial of supportive text messages for patients with alcohol use disorders and co-morbid depression, the investigators established that patients who received twice daily supportive text messages for three months had significantly less depressive symptoms than those who did not receive such messages. There was also a trend to finding that patients who received the supportive text messages were more likely to have higher cumulative abstinence duration than those who did not receive any supportive text messages. This research seeks to extend the knowledge gained from the pilot trial. A randomised trial will be conducted on a larger sample size of patients with alcohol use disorder and a co-morbid depressive disorder (including bipolar depression) for an extended duration (6 months of supportive text messages and 1 year follow-up instead of 3 months text messages with 6 months follow-up in the pilot trial). It is hypothesised that patients receiving supportive text messages will report significantly greater cumulative abstinence duration as well as significantly less relapses, hospitalizations and mood symptoms than those not receiving such messages. It is anticipated that this technology intervention for relapse prevention will be acceptable to patients as well as cost effective.
Interventions
OTHERSupportive text messages intervention
The supportive text messages are based on existing aphorisms in the recovery literature. Each day patients will receive one message targeting mood and another message targeting abstinence from alcohol in accordance with the primary aims of our study. An example text message aimed at improving mood is: Monitor changes in your mood; develop a list of personal warning signs. An example message targeting abstinence is: Keep Sobriety as a number one priority and you will reach your goals. None of the messages will be repeated. The messages will be sent in the morning and evening, with the theme (mood/alcohol) of the messages pseudo-randomised according to delivery time, so that no more than three successive days will have the same theme sent at the same time slot.
OTHERControl group
The control group will receive treatment as usual, as well as fortnightly thank you text messages and calls to ensure that they are still using their phone.
Sponsors
University of Dublin, Trinity College
St Patrick's Hospital, Ireland
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
1. Patients who meet the criteria for both alcohol dependency syndrome/alcohol abuse and either major depressive disorder or bipolar disorder according to the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) and are enrolled on the in-patient dual diagnosis or addiction treatment programmes in St. Patrick's University Hospital. 2. Able to provide written, informed consent. 3. Mini-mental state examination (MMSE) score of ≥ 25 4. Patients who have a mobile phone, are familiar with SMS text messaging technology and are willing to take part in the study.
Exclusion criteria
1. Patients who do not consent to take part in the study. 2. Patients who do not have a mobile phone or are unable to use the mobile text message technology. 3. Patients who would be unavailable for follow-up during the study period
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cumulative abstinence duration (CAD). | 12 months following discharge from the inpatient treatment programme. | CAD will be assessed using the timeline to follow-back (TLFB). This will be used to record the quantity of alcohol consumed and number of drinking days. |
| Changes in Beck's Depression Inventory (BDI) scores from baseline. | BDI will be administered at baseline (during the in-patient treatment programme for dual diagnosis), and then at 3, 6, 9 and 12 months post-discharge from hospital. | The BDI is a self-administered questionnaire widely used to assess depressive symptoms. It takes approximately 5 minutes to complete. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Perception of patients in the intervention group about the usefulness of supportive text messages. | 6 months post-discharge | Patient perceptions about the usefulness of the intervention will be assessed at the end of the intervention period in an interview. |
| Changes from baseline in scores on the modified global assessment of function (m-GAF) scale. | This assessment will be completed at baseline and then at 3, 6, 9 and 12 months. | The m-GAF will be used to measure subjective changes in the social, occupational and psychological functioning of the patients over the course of the study. |
| Changes from baseline in scores on the alcohol expectancy questionnaire (AEQ). | This scale will be administered at baseline and then at 3, 6, 9 and 12 months. | This scale will measure changes in attitudes towards alcohol over the course of the study. |
| Changes from baseline in scores on the obsessive compulsive drinking scale (OCDS). | This scale will be administered at baseline and then at 3, 6, 9 and 12 months. | This scale will measure changes in obsessive compulsive thoughts about alcohol over the 12 months of the study. |
| Proportion of patients continuously abstinent from alcohol at 6 and 12 months. | 6 and 12 months post-discharge. | Continuous abstinence will be assessed using the TLFB. |
| Changes from baseline in scores on the perceived stress scale (PSS). | This scale will be administered at baseline and then at 3, 6, 9 and 12 months. | This scale will measure changes in perceived stress over the 12 months of the study. This construct is closely related to resilience, which is a positive predictor of recovery in addiction. |
| Changes from baseline in scores on the young mania rating scale (YMRS). | This assessment will be completed at baseline and then at 3, 6, 9 and 12 months. | This subjective rating scale assesses the level of mania in patients with bipolar disorder (BP). It will be used to track changes in the manic symptoms of the BP patients over the 12 months of the study. |
| Changes from baseline in blood measures of alcohol abuse. | Blood samples will be analysed at baseline, then at 3, 6, 9 and 12 months following discharge. | Three blood measures suggestive of alcohol abuse will be taken to corroborate self-report measures of alcohol intake or abstinence from the TLFB- gamma glutamyl transferase (GGT), alkaline phosphatase (AST) and mean corpuscular volume (MCV). |
| Patient satisfaction with overall treatment protocol in both groups | 3, 6, 9 and 12 months | Patient satisfaction will be assessed using an adaptation of a treatment evaluation questionnaire. |
| Changes from baseline in scores on the alcohol abstinence self-efficacy scale (AASES). | These scales will be administered at baseline and then at 3, 6, 9 and 12 months. | This scale will measure changes in feelings of self-efficacy and personal control around drinking over the 12 months of the study. |
| Time to first drink. | 3, 6, 9 and 12 months post-discharge. | The time between the patient's discharge from hospital and their first drink, if any, during the study, will be measured using the TLFB. |
Countries
Ireland
Outcome results
None listed